The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
May 25th 2023
An analysis of data from the ARIC study is offering new insight into the impact of age at diabetes onset on the risk of developing dementia later in life.
Analysis of T1D Prevention Trials Sheds Light on Pitfalls, Factors Linked to Low ScreeningJanuary 11th 2023
An analysis of data from type 1 diabetes prevention trials is shedding new light on factors associated with increased and decreased likelihood of screening for type 1 diabetes among participants considered eligible for each trial.
Presence of Diabetes Linked to Greater Likelihood of Frozen ShoulderJanuary 10th 2023
Eight studies provided evidence to suggest the relationship between diabetes and the onset of frozen shoulder, but more high-quality cohort studies may be necessary to better understand the nature of the relationship.
Endocrine Case Report: Antibiotics Not WorkingJanuary 3rd 2023
A patient in their mid-50s with a history of diabetes who had already been on antibiotics for 4 days for cellulitis diagnosed in your emergency department, but had not improved, and then, yesterday, noticed an ankle wound. What additional testing should be considered for this patient?
Top FDA News in Diabetes for 2022December 26th 2022
Our editorial team is kicking off the final week of the year by recapping our the most talked about approvals and clearances related to diabetes management from the US Food and Drug Administration in 2022, including tirzepatide, teplizumab, Dexcom G7, and more!
Endocrine Month in Review: December 2022December 24th 2022
The last full weekend of each month, our editorial team compiles a list of our most popular endocrinology content from the past month for a month in review recap. The December 2022 endocrinology month in review features coverage of the FDA’s clearance of Dexcom G7, new data related to use of SGLT2 inhibitors in pediatric type 2 diabetes, and the ADA's Standards of Care in Diabetes—2023.
Endocrine Society Releases Updated Guidance for Management of HypoglycemiaDecember 7th 2022
The Endocrine Society has released updated guidance for management of hypoglycemia in people with diabetes, which represents their first guidance on the topic since 2009 and places a new emphasis on the role of diabetes technology, insulin analogs, and glucagon use.
Oral Butyrate Supplementation Could Be Effective in Treating Pediatric ObesityDecember 6th 2022
Data from the BAPO trial suggests use of oral butyrate supplementation was associated with a 40% absolute increase in rate of the trial's BMI-based primary outcome at 6 months relative to placebo therapy in a population of pediatric patients with obesity.
How Evolving Safety Has Changed the Outlook on Bariatric, Metabolic Surgery, with Gregory Weiss, MDDecember 2nd 2022
Gregory Weiss, MD, provides perspective on how improved safety of these procedures has revolutionized the way clinicians view use of bariatric and metabolic surgeries as a method for inducing weight loss in people with overweight and obesity.
Female Sex, Increased BMI Linked to Increased Likelihood of Long COVIDDecember 1st 2022
An analysis of survey data from more than 1400 adults in the UK provides insight into potential risk factors for developing long COVID symptoms, with results indicating both female sex and increased body mass index as potential risk factors.
Black Patients Less Likely to be Prescribed, Have Discussions around CGMs, Insulin PumpsNovember 24th 2022
A Johns Hopkins-led analysis provides a snapshot of trends in racial disparities seen in both uptake of and engagement in discussions with providers around continuous glucose monitoring and insulin pumps among adults with type 1 diabetes.
FDA Issues Recall for Insulet Devices for Battery, Overheating Issues that Could Cause FireNovember 17th 2022
Announced on November 17, the US FDA Class I recall for the Insulet Omnipod DASH Insulin Management System Personal Diabetes Manager comes after the company had received more than 450 complaints related to battery swelling, fluid leakage from battery, and extreme overheating, including 3 instances that included fires.
Flash Monitoring Could Prove Useful for Glucose Monitoring in Hemodialysis, Regardless of Diabetes StatusNovember 15th 2022
A 15-person study comparing flash monitoring to standard self-monitoring in people on hemodialysis with or without diabetes provides clinicians and researchers with insight into the potential clinical applicability of these devices in similar patient populations.
Diabetes Dialogue: Obesity Updates, with Lydia Alexander, MDNovember 14th 2022
In this episode, our hosts are joined by Lydia Alexander, MD, president-elect of the Obesity Medicine Association, to discuss the updates in the landscape of obesity management as well as a deep dive into the recent American Gastroenterological Association guidelines for pharmacological management and the OMA's annual meeting.
Study Finds Dexcom G7 Setup is Easier, Requires Fewer Tasks for Older Adults than Previous GenerationsNovember 10th 2022
A formal task analysis conducted in older adults with type 2 diabetes provides insight into the ease of use and task burden associated with uptake of the Dexcom G7 CGM system, with results indicating use of the system required fewer than half as many steps to initiate as previous generations of the CGM system.
Role of Obesity Management in Cardiovascular Disease Prevention, with Diana Isaacs, PharmDNovember 9th 2022
At AHA 2022, Diana Isaacs, PharmD, provides perspective on the potential impact of optimized uptake of newer obesity medications could have on population-level cardiovascular disease prevention.